We are live on ! Find out more
ACM

Altrius Capital Management Portfolio holdings

AUM $503M
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
-3.21%
1 Year Est. Return
+19.46%
3 Year Est. Return
+40.58%
5 Year Est. Return
10 Year Est. Return
AUM
$380M
AUM Growth
-$16.9M
Cap. Flow
+$1.57M
Cap. Flow %
0.41%
Top 10 Hldgs %
21.76%
Holding
92
New
3
Increased
63
Reduced
18
Closed
4

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$4.48M
2
WBA
Walgreens Boots Alliance
WBA
+$1.21M
3
PKX icon
POSCO
PKX
+$1.08M
4
STLA icon
Stellantis
STLA
+$1.06M
5
BMY icon
Bristol-Myers Squibb
BMY
+$899K

Top Sells

Rank Stock Value
1
PUK icon
Prudential
PUK
+$7.23M
2
AIG icon
American International
AIG
+$5.02M
3
R icon
Ryder
R
+$4.22M
4
INTC icon
Intel
INTC
+$3.92M
5
AVGO icon
Broadcom
AVGO
+$1.43M

Sector Composition

Rank Sector Weight
1 Healthcare 20.66%
2 Industrials 12.48%
3 Financials 10.15%
4 Consumer Discretionary 9.68%
5 Consumer Staples 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
26
3M
MMM
$91.8B
$4.81M 1.27%
47,115
-2,348
-5% -$229K
EMR icon
27
Emerson Electric
EMR
$81.6B
$4.69M 1.23%
42,566
+17
+0% +$1.88K
IBM icon
28
IBM
IBM
$213B
$4.65M 1.22%
26,884
+812
+3% +$141K
GD icon
29
General Dynamics
GD
$103B
$4.64M 1.22%
15,999
+41
+0.3% +$12K
MO icon
30
Altria Group
MO
$125B
$4.63M 1.22%
101,537
+2,048
+2% +$90.9K
CAH icon
31
Cardinal Health
CAH
$53.7B
$4.6M 1.21%
46,781
+1,940
+4% +$198K
MRK icon
32
Merck
MRK
$322B
$4.59M 1.21%
37,101
+57
+0.2% +$7.34K
CAT icon
33
Caterpillar
CAT
$361B
$4.59M 1.21%
13,772
+318
+2% +$110K
CSCO icon
34
Cisco
CSCO
$443B
$4.54M 1.2%
95,579
+9,127
+11% +$433K
CI icon
35
Cigna
CI
$78.4B
$4.54M 1.19%
13,728
+251
+2% +$86.6K
VZ icon
36
Verizon
VZ
$197B
$4.53M 1.19%
109,757
+304
+0.3% +$12.3K
JPM icon
37
JPMorgan Chase
JPM
$916B
$4.51M 1.19%
22,283
+110
+0.5% +$21.5K
EMN icon
38
Eastman Chemical
EMN
$7.69B
$4.5M 1.19%
45,964
+265
+0.6% +$26.3K
XOM icon
39
ExxonMobil
XOM
$650B
$4.47M 1.18%
38,843
+55
+0.1% +$6.41K
ABBV icon
40
AbbVie
ABBV
$465B
$4.46M 1.17%
26,014
+1,453
+6% +$241K
CVX icon
41
Chevron
CVX
$382B
$4.41M 1.16%
28,192
+1,421
+5% +$227K
GILD icon
42
Gilead Sciences
GILD
$165B
$4.41M 1.16%
64,212
+11,232
+21% +$750K
PG icon
43
Procter & Gamble
PG
$340B
$4.4M 1.16%
26,695
+656
+3% +$107K
SBUX icon
44
Starbucks
SBUX
$119B
$4.28M 1.13%
+55,009
New +$4.48M
BXP icon
45
Boston Properties
BXP
$11.6B
$4.23M 1.11%
68,698
+7,151
+12% +$437K
TSN icon
46
Tyson Foods
TSN
$21.5B
$4.22M 1.11%
73,848
+892
+1% +$52.1K
LMT icon
47
Lockheed Martin
LMT
$131B
$4.2M 1.11%
8,986
+169
+2% +$78.1K
PSX icon
48
Phillips 66
PSX
$82.9B
$4.17M 1.1%
29,561
+400
+1% +$59.2K
PFE icon
49
Pfizer
PFE
$143B
$4.15M 1.09%
148,234
+2,330
+2% +$64.1K
JNJ icon
50
Johnson & Johnson
JNJ
$640B
$4.12M 1.09%
28,222
+3,210
+13% +$477K

Similar funds

Altrius Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Altrius Capital Management held 92 positions worth $380M, down 4.3% from $397M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Altrius Capital Management's Q2 2024 filing shows 3 new, 63 increased, 18 reduced and 4 closed positions. Its largest new stake was Starbucks: 55,009 shares worth $4.28M. The largest sale was Prudential, an estimated $7.23M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.

  • Altrius Capital Management's largest Q2 2024 buy was Starbucks: 55,009 shares worth $4.28M.
  • Altrius Capital Management added most to Walgreens Boots Alliance in Q2 2024, an estimated $1.21M increase.
  • Altrius Capital Management's biggest Q2 2024 reduction was Broadcom, cutting an estimated $1.43M.
  • Altrius Capital Management fully exited Prudential in Q2 2024, selling an estimated $7.23M.
  • Altrius Capital Management's ten largest holdings make up 22% of its $380M portfolio in Q2 2024.
  • Altrius Capital Management opened 3 new positions and closed 4 in Q2 2024.
  • Altrius Capital Management's portfolio value fell 4.3% quarter-over-quarter to $380M.

Based on Altrius Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.